Navigation Links
BioMS Medical Announces Third Quarter 2009 Results
Date:11/12/2009

------------------------- --------------------------- --------------------------- Basic and diluted net income (loss) per common share 0.11 (0.01) 0.11 0.07 --------------------------- --------------------------- --------------------------- --------------------------- Basic weighted average number of common shares outstanding 91,009 91,261 91,009 91,112 --------------------------- --------------------------- --------------------------- --------------------------- Diluted weighted average number of common shares outstanding 91,009 91,261 91,009 91,919 --------------------------- --------------------------- --------------------------- --------------------------- BioMS Medical Corp Interim Consolidated Statements of Cash Flows (Unaudited) ------------------------------------------------------------------------- (expressed in thousands of Canadian dollars) Nine-month period ended Three-month period ended September 30, September 30, --------------------------- --------------------------- 2009 2008 2009 2008 $ $ $ $ Cash provided by (used in) Operating activities Net income (loss) 10,053 (774) 9,948 6,313 Items not involving cash Stock-based compensation 2,098 2,175 - 7 Amortization of licensing costs 736 1,103 - 368 Amortization of property and
'/>"/>
SOURCE BioMS Medical Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. BioMS Medical announces second quarter 2009 results
2. BioMS Medical to present at the 2009 Symposium for the Canadian Society for Pharmaceutical Sciences
3. BioMS Medical to participate in panel session at Bio International Convention 2009
4. BioMS Medical Announces First quarter 2009 results
5. BioMS Medical to present at Alberta Economic Forum in Geneva
6. BioMS Medical to present at BioFinance 2009
7. BioMS Medicals pivotal international multiple sclerosis trial receives positive review from Data Safety Monitoring Board
8. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
9. BioMS Medical Announces 2008 Year End Results
10. BioMS Medical warrant extension
11. BioMS Medical to present at BIO CEO and Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... 2014   Synthetic Biologics, Inc. ... therapies for serious infections and diseases, with ... announced positive topline safety and tolerability results ... SYN-004, the Company,s investigational oral beta-lactamase enzyme ... (C. difficile) infection, antibiotic-associated diarrhea and ...
(Date:12/22/2014)... -- GenomeDx Biosciences today announced that a new study ... test for prostate cancer, was able to predict rapid ... prostatectomy without adjuvant therapy. Although rapid metastasis in men ... genomics to identify these men who have a highly ... The study has been published online by the ...
(Date:12/22/2014)... ITRA Global, one of the largest organizations dedicated ... has further expanded its global reach with the affiliation ... Australia, reports Mylinda Vick, CCIM, Chairman of the ITRA ... ACORPP (Australian Corporate Property and Projects) , is a ... to a wide range of clients in the private ...
(Date:12/19/2014)... Charm Sciences is pleased to announce that ... Aflatoxin M1 in raw commingled milk is the first ... The peer reviewed report of the validation by Technology ... and Fisheries Research (ILVO-T&V) has been published by the ... most toxic aflatoxin and a known carcinogen, can be ...
Breaking Biology Technology:Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 2Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 3ITRA Global Continues International Expansion in Perth and Brisbane, Australia 2Charm Sciences Achieves Independent Validation of First 15 Minute Quantitative Screening Method for Aflatoxin M1 2
... 23, 2011 Genesis Biopharma, Inc. (OTC.BB:GNBP), a biotechnology ... California Governor, Gray Davis, has joined the company as ... committed to the improvement of healthcare and advancement of ... California became a leader in stem cell research as ...
... Syngenta announced today that it plans to construct a ... research campus in Research Triangle Park, North Carolina. The ... June 2011, will focus on discovering and developing new ... the world.   "This investment demonstrates ...
... May 20, 2011 Dendreon Corporation (Nasdaq: DNDN ) ... ThinkEquity Annual Healthcare Conference in New York City, NY ... Annual Global Healthcare Conference in Rancho Palos Verdes, CA on June ... presentations will be webcast live and available for replay from Dendreon,s ...
Cached Biology Technology:Governor Gray Davis Joins Genesis Biopharma as Chairman of Corporate Advisory Board 2Syngenta to Invest in New U.S. Genetics Research Facility 2
(Date:12/11/2014)... 2014  Data Sciences International (DSI), the global ... new series of digital telemetry implants to meet ... series, part of the PhysioTel™ Digital platform, was ... physiologic data when incorporating functional endpoints into repeat-dose ... toxicology studies has evolved from short ECG strips ...
(Date:12/10/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/xclcvw/biometrics_market ) ... Market in Japan 2014-2018" report to their ... The integration of biometrics and smart ... upgradation of the driver,s license is one of ... the aforementioned projects, biometrics is being used as ...
(Date:12/3/2014)... , Dec. 2, 2014   Marvin Test ... innovative test solutions for military, aerospace, and manufacturing ... of its successful TS-900 PXI semiconductor test ... features of high-end systems to customers at a ... compared to traditional ATE. "Our ...
Breaking Biology News(10 mins):New telemetry implants expected to change how large animal toxicology studies are conducted 2Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3
... the new research results of the VTT Technical Research Centre ... of high-quality biofuels for the price of less than one ... the transfer of more than half the energy of wood ... for the construction of a commercial-scale production plant in Europe. ...
... Amsterdam, July 3, 2013 - Elsevier, a world-leading provider ... today announced the publication of a recent retrospective study ... better understand treatment considerations and outcomes for same-sex male ... The number of same-sex male couples and single ...
... has produced a potential new antibiotic which could help ... The potential new antibiotic targets a bacterial enzyme critical ... inhibitor which binds to the enzyme (called biotin protein ... of the bacteria. "Existing antibiotics target the bacterial ...
Cached Biology News:Gasification method turns forest residues to biofuel with less than a euro per liter 2Reproductive BioMedicine Online publishes study on assisted reproduction 2Novel chemistry for new class of antibiotic 2
... Series Multimode Detectors provide unmatched value ... application and automation needs. Capable of ... on the same instrument, the DTX ... or can be integrated seamlessly with ...
... Solution is available in a ready-to-use ... reagent for dewaxing paraffin-embedded tissue sections ... hybridization, or other analytical methods. The ... of dipping the slides in a ...
... The MJ Mini thermal cycler is a compact ... x 0.2 ml tubes, 12 x 0.5 ml ... heated lid uses a thumbwheel to adjust height ... oil-free cycling. Peltier heat pumps provide excellent thermal ...
MiniCycler thermal cycler with Hot Bonnet heated lid, holds 25x0.2ml tubes...
Biology Products: